When sleep is off, even slightly, so are your hunger cues
The peptide's structure contains the 4-10 melanocortin receptor binding region common to -MSH and adrenocorticotropin (ACTH), but incorporates a lactam bridge between amino acids 4 and 10, along with specific amino acid substitutions (Nle4, Asp5, D-Phe7, Lys10) that enhance receptor binding affinity and metabolic stability
For many individuals, it becomes the first medication that allows them to feel in command of their appetite rather than reacting to constant hunger cues
These medications tap into the GLP-1 pathway to help reduce appetite and increase feelings of fullness, supporting lasting weight loss
The dose starts at 0.25 mg and increases every 4 weeks until reaching a maintenance dose, usually 2.4 mg